Click here to create your personal news page. The news that appears on Invitrogen Corporation will appear there and be constantly updated. You can then modify the page, share it with your friends, or export it and have it appear elsewhere.

You can also create a personal news page and follow the news that interests you by clicking on the tab labelled 'New page'.
 

topics : related - allExplore

Wikio Shopping (beta)

  1. 1. Computers
  2. 2. Electronics
  3. 3. Communication
  4. 4. Household Appliances
  5. 5. Car/Motor Bike
  6. 6. Digital Camera
  7. 7. Mobile Phone
  8. 8. Smartphone
  9. 9. PDA
  10. 10. GPS
  11. 11. LCD Monitor
  12. 12. Printer

New products

  1. 1. Sony TA-DA6400ES
  2. 2. Yamaha RX-V3900
  3. 3. Mitac MiSTATION
  4. 4. Panasonic SC-H7
  5. 5. NEC MultiSync EA221WM
  6. 6. Liteon eSAU208
  7. 7. Toshiba 26AV550
  8. go to Shopping

Participate



Invitrogen Corporation


Sort by : relevance - date
+Vote!

Invitrogen Names Joe Beery Senior Vice President, Chief Information Officer

CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the

1Vote!

Invitrogen Launches Patent Licensing Program for Enabling Amplification Technology

CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced that it

+Vote!

Invitrogen Sets Date for Special Meeting of Shareholders to Vote on Proposed Merger with Applied Biosystems

CARLSBAD, Calif. - Invitrogen Corporation (NASDAQ:IVGN) today announced it has set the date for a special meeting of its shareholders, to consider the proposed acquisition of Applied Biosystems Inc. The special meeting of shareholders will be held on October 16, 2008, at 9 a.m., PT at

1Vote!

Invitrogen Sets Date for Special Meeting of Shareholders to Vote on Proposed Merger with Applied Biosystems

CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN) today announced it has set the date for a special meeting of its shareholders, to consider the proposed acquisition of

+Vote!

Invitrogen Launches Legionella Test to Streamline Surveillance

CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced today the

1Vote!

Invitrogen Launches Legionella Test to Streamline Surveillance

Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced today the launch of its Dynabeads(R) MAX Legionella, which enables a unique process for targeting and concentrating legionella from environmental water samples.

+Vote!

Invitrogen, Lentigen to Provide Lentivirus Products and Services for Gene Over-Expression

CARLSBAD, Calif. & BALTIMORE--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, and Lentigen

+Vote!

Invitrogen Licenses Stem Cell Line from Buck Institute

CARLSBAD, Calif. & NOVATO, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, has

1Vote!

Invitrogen and Applied Biosystems Announce Expiration of Hart-Scott-Rodino Waiting Period

CARLSBAD, Calif. & FOSTER CITY, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ: IVGN) and Applied Biosystems Inc. (NYSE: ABI) today announced the expiration of the waiting period under the

+Vote!

Invitrogen Licenses Stem Cell Line From Buck Institute

Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, has licensed an engineered stem cell line from the Buck Institute for Age Research.

+Vote!

Invitrogen Announces Second Quarter 2008 Financial Results

CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (Nasdaq:IVGN) today announced results for its second quarter ended June 30, 2008. Revenues for the second quarter were

+Vote!

Active Motif, Inc.: Invitrogen and Active Motif Explore Use of FPGA Technology for Next-Generation Sequencing Data Analysis

CARLSBAD, CA (MARKET WIRE) Invitrogen Corporation, a provider of essential life science technologies for research, production and diagnostics, and Active Motif, Inc., developer of TimeLogic(R) hardware-accelerated genomics solutions, have announced a joint project to explore the use of field programmable gate array (FPGA) technology for the analysis of next-generation sequencing data....

+Vote!

Invitrogen and Active Motif Explore Use of FPGA Technology for Next-Generation Sequencing Data Analysis

CARLSBAD, CA -- 07/21/08 -- Invitrogen Corporation, a provider of essential life science technologies for research, production and diagnostics, and Active Motif, Inc., developer of TimeLogic® hardware-accelerated genomics solutions, have annou..

+Vote!

Applied Biosystems to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference on September 9

Applied Biosystems Inc. (formerly known as Applera Corporation) is a global leader in the development and marketing of instrument-based systems, consumables, software, and services for academic research, the life science industry and commercial markets. Driven by its employees' belief in the power of science to improve the human condition, the company commercializes innovative technology solutions...

1Vote!

Applied Biosystems Announces Internet Availability of Its 2008 Annual Report on Form 10-K

Applied Biosystems Inc. (formerly known as Applera Corporation) is a global leader in the development and marketing of instrument-based systems, consumables, software, and services for academic research, the life science industry and commercial markets. Driven by its employees' belief in the power of science to improve the human condition, the company commercializes innovative technology solutions...